Merial, Inc. v. Sergeant's Pet Care Prods.

CourtCourt of Appeals for the Sixth Circuit
DecidedMarch 18, 2020
Docket19-1133
StatusUnpublished

This text of Merial, Inc. v. Sergeant's Pet Care Prods. (Merial, Inc. v. Sergeant's Pet Care Prods.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Merial, Inc. v. Sergeant's Pet Care Prods., (6th Cir. 2020).

Opinion

NOT RECOMMENDED FOR PUBLICATION File Name: 20a0162n.06

No. 19-1133

UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT FILED Mar 18, 2020 MERIAL, INC., ) DEBORAH S. HUNT, Clerk ) Plaintiff-Appellant, ) ) ON APPEAL FROM THE v. ) UNITED STATES DISTRICT ) COURT FOR THE WESTERN SERGEANT’S PET CARE PRODUCTS, INC., ) DISTRICT OF MICHIGAN ) Defendant-Appellee. ) )

BEFORE: BOGGS, BATCHELDER, and DONALD, Circuit Judges.

BOGGS, Circuit Judge. Merial, the maker of the popular Frontline Plus flea control product

for pets, had been fighting for years with two competitors (Sergeant’s and Velcera) who, it alleged,

were infringing on its patent for that product. Just when the parties seemed to have resolved their

disputes through a series of contracts, market forces threw everything into chaos: Merial’s two

competitors merged with or were bought by a third (Perrigo), bringing their contractual obligations

under one roof. Since one agreement functioned as a license to manufacture a generic version of

Frontline Plus, and the other as a prohibition on doing so, this created problems. Problems become

lawsuits. This lawsuit came to the Northern District of Georgia, where a judge ruled in favor of

Perrigo, holding (in relevant part) that it had a right to produce the generic version of Frontline

Plus.

When Merial then pursued an action against only Sergeant’s (now a Perrigo subsidiary)

in Michigan, the U.S. District Court for the Western District of Michigan dismissed the new suit No. 19-1133, Merial, Inc. v. Sergeant’s Pet Care Products, Inc.

on the grounds of collateral estoppel, citing the Georgia ruling. But it is far from clear that the

Georgia ruling should be preclusive. Its language is tangled and (as to the question before us)

contradictory. Moreover, Sergeant’s is a corporate entity distinct from Perrigo, and a ruling as to

Sergeant’s liability does not appear to have been necessary to the Georgia decision. Therefore,

though the question is a close one, we reverse.

I. FACTUAL AND PROCEDURAL HISTORY

In the beginning, Merial, a French animal-health company, developed and patented a flea-

and-tick medicine for dogs and cats known as “Frontline Plus.” Frontline Plus was covered by

U.S. Patent No. 6,096,329 (the “’329 Patent”), which was granted in 2000 and ran until August

2016. See ibid. However, this popular product soon drew competitors, not to say imitators. In 2010,

Sergeant’s Pet Care Products filed a request for reexamination with the U.S. Patent and Trademark

Office (“U.S.P.T.O”) and, in early 2011 while that request was pending, began selling a competing

“combination product” (a generic term for Frontline Plus and its competitors, which work through

a combination of the pesticides fipronil and methoprene.)

In April 2011, Sergeant’s and Merial resolved their dispute in what became known as the

“Sergeant’s Agreement,” under which Sergeant’s undertook to refrain from selling combination

products during the life of the ’329 Patent if the U.S.P.T.O. found in Merial’s favor—which it

subsequently did.

Meanwhile, in 2012, Merial entered into another agreement with a different competitor,

Velcera, who was also making a combination product. The terms of the “Velcera Agreement” (also

referred to in the multiple lawsuits to come as the “Master Settlement Agreement” or “MSA”)

were different from those of the Sergeant’s Agreement: the Velcera Agreement was in essence a

license to sell the knock-off Frontline after 2014 in exchange for royalty payments and certain

-2- No. 19-1133, Merial, Inc. v. Sergeant’s Pet Care Products, Inc.

protections. Specifically, Velcera agreed not to sell infringing combination products until

November 30, 2014, after which it could do so in exchange for a royalty payment to Merial of 8%

of all sales until the ’329 Patent expired. To protect its newly-acquired license, Velcera also

obtained a promise from Merial that Merial would not grant a license, covenant not to sue, or

permission to infringe the patent to any other competitor, and that Merial would notify Velcera if

it in fact did so.

However, disturbances were ahead for this well-settled universe. On September 12, 2012,

a drug company named Perrigo acquired Sergeant’s through an asset-purchase agreement. On

September 14, 2012, Perrigo incorporated a new, wholly-owned subsidiary, Perrigo Animal

Health, and thereafter transferred Sergeant’s assets to the subsidiary, which also resumed using the

name Sergeant’s. Then, in April 2013, Perrigo merged with Velcera “and became the sole owner

of all Velcera assets, including flea and tick products.” Perrigo Co. v. Merial, Ltd., 267 F. Supp.

3d 1364, 1367 (N.D. Ga. 2017) (cleaned up). Now, the counterparties to the Sergeant’s Agreement

and the Velcera Agreement were under one corporate roof.

Trouble sprang up quickly from both directions. As Perrigo began preparing to release an

infringing product pursuant to the Velcera Agreement, it became clear to Merial—with whom

Perrigo was obligated to negotiate a mutually acceptable press release—that Perrigo was taking

the position that, due to the Velcera Agreement, it could also produce and release infringing

products through Sergeant’s. Meanwhile, Perrigo heard rumors through industry channels that

Merial had granted a license to an unrelated animal-products company, Ceva Animal Health,

without notifying Perrigo. See 267 F. Supp. 3d at 1368. Interactions produced little but falsehoods

(Merial reassured Perrigo that it had not issued another license) and evasions (Perrigo sidestepped

Merial’s inquiries about whether it would be putting out infringing products through Sergeant’s).

-3- No. 19-1133, Merial, Inc. v. Sergeant’s Pet Care Products, Inc.

Shortly after November 30, 2014, Perrigo released FiproGuard Plus and PetArmor Plus—which

were infringing products—through Sergeant’s. Around the same time, Perrigo was able to confirm

the rumors: Merial had in fact granted a license to Ceva.

On December 12, 2014, Perrigo, Sergeant’s, Velcera, and FidoPharm (a subsidiary of

Velcera) sued Merial in the District of Nebraska, alleging breach of the Velcera Agreement. Id. at

1369; see Dkt. 1, Perrigo Co. v. Merial Ltd., No. 8:14-cv-00403 (D. Neb.) [hereinafter “D. Neb.

Dkt.”]. Two weeks later, Merial sued Perrigo and the other three companies in the Northern District

of Georgia, alleging breach of the Sergeant’s Agreement. Merial moved in Nebraska to dismiss

the case or, in the alternative, to transfer it to Georgia. The judge denied the first motion and held

further arguments on the second. In October 2015, the District of Nebraska granted the motion to

transfer the case to the Northern District of Georgia, citing judicial economy. See D. Neb. Dkt.

114. Once both cases were in Georgia, Merial moved to consolidate, which the court granted. Then

the trouble started. Merial filed for partial summary judgment in the case in which it was the

plaintiff (“the 13 case”)1; meanwhile, Perrigo and the other three affiliated entities moved to

dismiss the 13 case for want of personal jurisdiction.

The court entertained the motion to dismiss first and granted it. (This had the odd result

that the only case still pending before the Northern District of Georgia was the 3674 case that had

been filed in Nebraska, and only moved to Georgia for reasons of judicial economy.) Merial thus

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Bestfoods
524 U.S. 51 (Supreme Court, 1998)
Taylor v. Sturgell
553 U.S. 880 (Supreme Court, 2008)
Arnold Maxwell Harris v. George Jacobs
621 F.2d 341 (Ninth Circuit, 1980)
United States v. Cinemark Usa, Inc.
348 F.3d 569 (Sixth Circuit, 2003)
Bies v. Bagley
535 F.3d 520 (Sixth Circuit, 2008)
Miller v. Nichols
586 F.3d 53 (First Circuit, 2009)
Kosinski v. Commissioner
541 F.3d 671 (Sixth Circuit, 2008)
Cobbins v. Tennessee Department of Transportation
566 F.3d 582 (Sixth Circuit, 2009)
Arkansas Coals, Inc. v. Albert Lawson
739 F.3d 309 (Sixth Circuit, 2014)
United States v. United Technologies Corp.
782 F.3d 718 (Sixth Circuit, 2015)
Browning v. Levy
283 F.3d 761 (Sixth Circuit, 2002)
Perrigo Co. v. Merial Ltd.
267 F. Supp. 3d 1364 (N.D. Georgia, 2017)
Connors v. Tanoma Mining Co.
953 F.2d 682 (D.C. Circuit, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
Merial, Inc. v. Sergeant's Pet Care Prods., Counsel Stack Legal Research, https://law.counselstack.com/opinion/merial-inc-v-sergeants-pet-care-prods-ca6-2020.